The company
Quantum-Si Incorporated
QSI · Nasdaq
QSI stood above a rising 150-day average in 5 of the last 52 weekly readings, including each of the last 2 weeks. It is 23.0% above that average now. Life Science Tools & Research Services: 52% of its 79 stocks in an uptrend (+4 points in four weeks); Health Care: 25% (−11 points in four weeks).
Statistics
- Rotation
- Just started moving
- Weeks in an uptrend
- 2 in a row
- Industry in uptrend
- 52% +4 in 4 wk
- Insider buys, 12 months
- $1.1M
- Insider sales, 12 months
- $903K
- Officials’ trades on record
- 0
- Institutions holding
- 135 (-11)
In the rotation
Each square a week: lit when it closed above a rising 150-day average. 5 of 52 weeks.
Life-science tools: About half its stocks are in an uptrend and the share has been climbing. Health Care: A minority of its stocks are in an uptrend and the share has fallen sharply over four weeks.
Money in and out
Open-market buys above the line and sales below, in dollars.
Congress and officials
No member of Congress or official has disclosed a trade in it.
Insiders
| Who | Did | Shares | Traded |
|---|---|---|---|
| Christian LapointeGC & Corp. Secretary | sold | 4,721at $0.7608 | 22 Sep 2026filed 23 Sep 2026 |
| Jeffry R. KeyesChief Financial Officer | sold | 2,493at $0.7608 | 22 Sep 2026filed 23 Sep 2026 |
| Jeffrey Alan HawkinsPresident & CEO | sold | 9,709at $0.7608 | 22 Sep 2026filed 23 Sep 2026 |
| Christian LapointeGC & Corp. Secretary | sold | 9,795at $0.7558 | 21 Sep 2026filed 23 Sep 2026 |
| Jeffry R. KeyesChief Financial Officer | sold | 5,172at $0.7558 | 21 Sep 2026filed 23 Sep 2026 |
| Jeffrey Alan HawkinsPresident & CEO | sold | 20,143at $0.7558 | 21 Sep 2026filed 23 Sep 2026 |
| Jeffrey Alan HawkinsPresident & CEO | sold | 11,311at $0.899 | 23 Jun 2026filed 24 Jun 2026 |
| John S. VieceliChief Product Officer | sold | 15,112at $0.899 | 23 Jun 2026filed 24 Jun 2026 |
| Jeffry R. KeyesChief Financial Officer | sold | 4,117at $0.899 | 23 Jun 2026filed 24 Jun 2026 |
| Christian LapointeGC & Corp. Secretary | sold | 7,794at $0.899 | 23 Jun 2026filed 24 Jun 2026 |
| Jeffrey Alan HawkinsPresident & CEO | sold | 11,310at $0.9574 | 22 Jun 2026filed 24 Jun 2026 |
| John S. VieceliChief Product Officer | sold | 15,111at $0.9574 | 22 Jun 2026filed 24 Jun 2026 |
Lines filed since 2 January 2026, newest first; every insider’s older lines are on their own page.
Institutions
Quarter to 30 Jun 2026, against 31 Mar 2026; newest filing 31 Aug 2026.
| Manager | Shares | Change |
|---|---|---|
| VANGUARD CAPITAL MANAGEMENT LLCadded · filed 13 Aug 2026 | 7,578,208$6.7M | +556,301+7.9% |
| ARK Investment Management LLCadded · filed 14 Aug 2026 | 7,167,738$6.3M | +288,839+4.2% |
| BlackRock, Inc.reduced · filed 7 Aug 2026 | 5,225,352$4.6M | -8,189,597−61.0% |
| Sumitomo Mitsui Trust Group, Inc.reduced · filed 30 Jul 2026 | 3,885,230$3.4M | -506,436−11.5% |
| Amova Asset Management Americas, Inc.reduced · filed 13 Aug 2026 | 3,885,230$3.5M | -506,436−11.5% |
| MILLENNIUM MANAGEMENT LLCnew · filed 14 Aug 2026 | 3,131,726$2.8M | +3,131,726 |
| UBS Group AGadded · filed 13 Aug 2026 | 2,561,897$2.3M | +859,370+50.5% |
| AQR CAPITAL MANAGEMENT LLCreduced · filed 14 Aug 2026 | 2,348,665$2.1M | -43,514−1.8% |
| GEODE CAPITAL MANAGEMENT, LLCreduced · filed 12 Aug 2026 | 2,236,526$2.0M | -1,598,595−41.7% |
| JANE STREET GROUP, LLCnew · filed 14 Aug 2026 | 2,142,735$1.9M | +2,142,735 |
News
No headline names it lately.
Everyone who traded it
Same industry
Government contracts
No federal award is tied to it.
From its SEC filings
Analyst forecasts
No analyst forecasts yet.